Kohji Abe

Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine _1A Receptor–Dependent Mechanism

Kenichi Mishima, Kazuhide Hayakawa, Kohji Abe et al. · Stroke · 2005 · 226 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats

Tetsuji Itoh, Miwa Tokumura, Kohji Abe · European Journal of Pharmacology · 2004 · 93 citations

Medicine, Neuroscience, Pharmacology +17

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics

Masahito Horiuchi, Megumi Kimura, Miwa Tokumura et al. · Toxicology · 2006 · 91 citations

Life Sciences, Pharmacology, Pharmacotherapy +16

Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

Kazuhide Hayakawa, Kenichi Mishima, Masanori Nozako et al. · Neuropharmacology · 2007 · 88 citations

Medicine, Neuroscience, Pharmacology +12

Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

Kazuhide Hayakawa, Kenichi Mishima, Masanori Nozako et al. · Journal of Neurochemistry · 2007 · 87 citations

Medicine, Neuroscience, Pharmacology +17